Hemerion
French tech company | Builders Republic
About
Clinical-stage medtech developing a first-in-class treatment for glioblastoma, the most aggressive brain cancer — pairing a light-activated drug (Pentalafen) with an illumination device (Heliance) used during surgery to destroy residual tumor cells after resection, limiting recurrence and extending survival.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Seed
- Founded
- 2020
- City
- VILLENEUVE-D'ASCQ
- Region
- Hauts-de-France
- Tracked rounds
- 1
- Amount raised
- 6.5 M€ raised since 2020
Funding rounds
- Seed — 2025